CSS
ENFN

Cubist Systematic Strategies’s Enfusion, Inc. ENFN Stock Holding History

Cubist Systematic Strategies’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-173,140
Closed -$1.78M – 3661
2024
Q4 		$1.78M Buy
+173,140
New +$1.67M 0.01% 1428
2023
Q2 		– Sell
-133,160
Closed -$1.4M – 4425
2023
Q1 		$1.4M Buy
+133,160
New +$1.47M 0.01% 1931
2022
Q1 		– Sell
-33,340
Closed -$698K – 3814
2021
Q4 		$698K Buy
+33,340
New +$674K 0.01% 2197

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Cubist Systematic Strategies's ENFN Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 173,140 shares — an estimated $1.78M sold.

Cubist Systematic Strategies first reported a position in ENFN in Q4 2021 and held it in 3 quarters. The position peaked at $1.78M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 173,140 Enfusion, Inc. shares in Q1 2025, an estimated $1.78M.
  • Cubist Systematic Strategies first reported a position in Enfusion, Inc. in Q4 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's Enfusion, Inc. position peaked at $1.78M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.